DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 5,190,000 shares, a decline of 20.3% from the April 30th total of 6,510,000 shares. Currently, 6.0% of the company’s stock are short sold. Based on an average trading volume of 1,230,000 shares, the days-to-cover ratio is currently 4.2 days.

DocGo Stock Performance

Shares of NASDAQ DCGO opened at $1.42 on Monday. The stock has a market cap of $144.31 million, a price-to-earnings ratio of 5.05, a PEG ratio of 14.16 and a beta of 1.14. The business has a 50 day simple moving average of $2.07 and a 200 day simple moving average of $3.44. DocGo has a 52 week low of $1.23 and a 52 week high of $5.68.

DocGo (NASDAQ:DCGO) last posted its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.08). DocGo had a return on equity of 8.90% and a net margin of 4.35%. The company had revenue of $96.03 million during the quarter, compared to analyst estimates of $104.25 million. On average, analysts predict that DocGo will post 0.25 EPS for the current year.

Institutional Investors Weigh In On DocGo

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Summit Securities Group LLC acquired a new stake in DocGo in the 1st quarter worth approximately $34,000. Summit Investment Advisors Inc. lifted its holdings in shares of DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after buying an additional 2,968 shares during the last quarter. Prudential Financial Inc. acquired a new position in shares of DocGo during the fourth quarter worth approximately $55,000. Royce & Associates LP acquired a new position in shares of DocGo during the fourth quarter worth approximately $64,000. Finally, Strs Ohio acquired a new position in shares of DocGo in the first quarter valued at $76,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on DCGO shares. Canaccord Genuity Group reaffirmed a “hold” rating and set a $1.45 target price (down previously from $5.00) on shares of DocGo in a research note on Monday, May 12th. Deutsche Bank Aktiengesellschaft cut DocGo from a “buy” rating to a “hold” rating and lowered their target price for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Stifel Nicolaus lowered their price target on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research note on Friday, February 28th. Needham & Company LLC lowered their price target on DocGo from $4.00 to $3.00 and set a “buy” rating for the company in a research note on Friday, May 9th. Finally, BTIG Research cut DocGo from a “buy” rating to a “neutral” rating in a research note on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $3.56.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.